Schwarz M - Search Results

1

Circulating annexin V positive microparticles in patients after successful cardiopulmonary resuscitation.

Fink K, Feldbrügge L, Schwarz M, Bourgeois N, Helbing T, Bode C, Schwab T, Busch HJ. Fink K, et al. Among authors: schwarz m. Crit Care. 2011;15(5):R251. doi: 10.1186/cc10512. Epub 2011 Oct 25. Crit Care. 2011. PMID: 22027379 Free PMC article.

2

Severe endothelial injury and subsequent repair in patients after successful cardiopulmonary resuscitation.

Fink K, Schwarz M, Feldbrügge L, Sunkomat JN, Schwab T, Bourgeois N, Olschewski M, von Zur Mühlen C, Bode C, Busch HJ. Fink K, et al. Among authors: schwarz m. Crit Care. 2010;14(3):R104. doi: 10.1186/cc9050. Epub 2010 Jun 4. Crit Care. 2010. PMID: 20525353 Free PMC article.

3

Mac-1 directly binds to the endothelial protein C-receptor: a link between the protein C anticoagulant pathway and inflammation?

Fink K, Busch HJ, Bourgeois N, Schwarz M, Wolf D, Zirlik A, Peter K, Bode C, von Zur Muhlen C. Fink K, et al. Among authors: schwarz m. PLoS One. 2013;8(2):e53103. doi: 10.1371/journal.pone.0053103. Epub 2013 Feb 7. PLoS One. 2013. PMID: 23408932 Free PMC article.

4

[Inhibition of plasmatic coagulation: what is new?].

Schwarz M, Bode C. Schwarz M, et al. Hamostaseologie. 2006 May;26(2):154-7. Hamostaseologie. 2006. PMID: 16676059 Review. German.

5

Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths.

von Zur Muhlen C, von Elverfeldt D, Choudhury RP, Ender J, Ahrens I, Schwarz M, Hennig J, Bode C, Peter K. von Zur Muhlen C, et al. Among authors: schwarz m. Mol Imaging. 2008 Mar-Apr;7(2):59-67. Mol Imaging. 2008. PMID: 18706288 Free PMC article.

6

Distinct roles of ligand affinity and cytoskeletal anchorage in alphaIIbbeta3 (GP IIb/IIIa)-mediated cell aggregation and adhesion.

Peter K, Ahrens I, Schwarz M, Bode C, Ylänne J. Peter K, et al. Among authors: schwarz m. Platelets. 2004 Nov;15(7):427-38. doi: 10.1080/09587100410001723179. Platelets. 2004. PMID: 15745314 Free article.

7

Intrinsic activating properties of GP IIb/IIIa blockers.

Peter K, Schwarz M, Nordt T, Bode C. Peter K, et al. Among authors: schwarz m. Thromb Res. 2001 Sep 30;103 Suppl 1:S21-7. doi: 10.1016/s0049-3848(01)00300-0. Thromb Res. 2001. PMID: 11567665 Review.

8

Reversibility versus persistence of GPIIb/IIIa blocker-induced conformational change of GPIIb/IIIa (alphaIIbbeta3, CD41/CD61).

Schwarz M, Katagiri Y, Kotani M, Bassler N, Loeffler C, Bode C, Peter K. Schwarz M, et al. J Pharmacol Exp Ther. 2004 Mar;308(3):1002-11. doi: 10.1124/jpet.103.058883. Epub 2003 Nov 14. J Pharmacol Exp Ther. 2004. PMID: 14617694

9

Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.

Peter K, Straub A, Kohler B, Volkmann M, Schwarz M, Kübler W, Bode C. Peter K, et al. Among authors: schwarz m. Am J Cardiol. 1999 Sep 1;84(5):519-24. doi: 10.1016/s0002-9149(99)00370-7. Am J Cardiol. 1999. PMID: 10482148

10

[Helping antibodies. Targeted antithrombotic and fibrinolytic therapy].

Schwarz M, Hagemeyer CE, Peter K, Bode C. Schwarz M, et al. Hamostaseologie. 2007 Dec;27(5):360-2. Hamostaseologie. 2007. PMID: 18060247 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,489 results

Search Page

Filters